Mumbai, May 18 (IANS). Consumer company Zydus Wellness released its FY26 results on Monday. The company’s profit has declined by 47 percent to Rs 197 crore for the entire last financial year. However, during this period, consolidated sales have increased by 46.4 percent to Rs 3,940 crore.
According to stock exchange filing, the company’s profit declined by 6 percent year-on-year to Rs 162 crore in the March quarter.
The company’s consolidated income from operations increased by 62.1 percent year-on-year to Rs 1,476 crore in the March quarter of FY26.
The company said revenue growth during the year was driven by the contribution of newly acquired businesses, although profits remained under pressure due to integration-related expenses and higher operating costs.
Operating performance remained relatively stable, with Ebitda growing by 34.2 per cent year-on-year to Rs 509 crore in FY26.
The board of directors has recommended a final dividend of Rs 1.20 per share of face value Rs 2 for FY26, subject to the approval of shareholders at the annual general meeting to be held on August 4.
The company said that among its key brands, Sugar Free continues to dominate the sugar substitute segment with 96.1 per cent market share.
The brand has also expanded into related categories by launching new products like Sugar Free D’Lite Choco Spread.
Protein snacking brand RiteBite Max Protein continued to scale its operations and achieve near double-digit EBITDA margins while improving profitability.
The company attributed this improvement to the launch of new products such as protein drinks and functional snack bars.
Hydration brand Glucon-D maintained its segment leadership with 58.9 percent market share while also expanding into performance hydration products.
In the skincare segment, EveryYouth maintained its strong market position in scrubs and peel-off masks, while Nysil maintained its leadership in the Prickly Heat Powder category.
The company further said that its broader nutraceutical and wellness portfolio, including brands such as Nutralite and Complan, maintained steady momentum during the year, although total earnings remained impacted due to acquisition-related cost pressures and integration expenses.
–IANS
abs/
